Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook
- PMID: 39566511
- DOI: 10.1515/znc-2024-0208
Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook
Abstract
An ideal drug carrier system should demonstrate optimal payload and release characteristics, thereby ensuring prolonged therapeutic index while minimizing adverse effects. The field of drug delivery has undergone significant advancements, particularly within the last two decades, owing to the revolutionary impact of biomaterials. The use of biomaterials presents significant due to their biocompatibility and biodegradability, which must be addressed in order to achieve effective drug delivery. The properties of the biomaterial and its interface are primarily influenced by their physicochemical attributes, physiological barriers, cellular trafficking, and immunomodulatory effects. By attuning these barriers, regulating the physicochemical properties, and masking the immune system's response, the bio interface can be effectively modulated, leading to the development of innovative supramolecular structures with enhanced effectiveness. With a comprehensive understanding of these technologies, there is a growing demand for repurposing existing drugs for new therapeutic indications within this space. This review aims to provide a substantial body of evidence showcasing the productiveness of biomaterials and their interface in drug delivery, as well as methods for mitigating and modulating barriers and physicochemical properties along with an examination of future prospects in this field.
Keywords: bio interface; biomaterial; cellular uptake; drug delivery; physicochemical.
© 2024 Walter de Gruyter GmbH, Berlin/Boston.
Similar articles
-
Insight into Silk-Based Biomaterials: From Physicochemical Attributes to Recent Biomedical Applications.ACS Appl Bio Mater. 2019 Dec 16;2(12):5460-5491. doi: 10.1021/acsabm.9b00576. Epub 2019 Sep 17. ACS Appl Bio Mater. 2019. PMID: 35021544
-
Hydroxyapatite: A journey from biomaterials to advanced functional materials.Adv Colloid Interface Sci. 2023 Nov;321:103013. doi: 10.1016/j.cis.2023.103013. Epub 2023 Oct 7. Adv Colloid Interface Sci. 2023. PMID: 37839281 Review.
-
Recent Review on Biological Barriers and Host-Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies.Pharmaceutics. 2024 Aug 16;16(8):1076. doi: 10.3390/pharmaceutics16081076. Pharmaceutics. 2024. PMID: 39204421 Free PMC article. Review.
-
Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy.Bioact Mater. 2022 Jan 19;17:29-48. doi: 10.1016/j.bioactmat.2022.01.011. eCollection 2022 Nov. Bioact Mater. 2022. PMID: 35386442 Free PMC article. Review.
-
Advancements in Polymer Biomaterials as Scaffolds for Corneal Endothelium Tissue Engineering.Polymers (Basel). 2024 Oct 12;16(20):2882. doi: 10.3390/polym16202882. Polymers (Basel). 2024. PMID: 39458711 Free PMC article. Review.
References
-
- Mainardes, RM, Silva, LP. Drug delivery systems: past, present, and future. Curr Drug Targets 2004;5:449–55. https://doi.org/10.2174/1389450043345407 . - DOI - PubMed
-
- Buckles, RG. Biomaterials for drug delivery systems. J Biomed Mater Res 1983;17:109–28. https://doi.org/10.1002/jbm.820170110 . - DOI - PubMed
-
- Adepu, S, Ramakrishna, S. Controlled drug delivery systems: current status and future directions. Molecules 2021;26:5905. https://doi.org/10.3390/molecules26195905 . - DOI - PubMed - PMC
-
- Peppas, NA, Langer, R. New challenges in biomaterials. Science 1994;263:1715–20. https://doi.org/10.1126/science.8134835 . - DOI - PubMed
-
- Sant, S, Tao, SL, Fisher, O, Xu, Q, Peppas, NA, Khademhosseini, A. Microfabrication technologies for oral drug delivery. Adv Drug Deliv Rev 2012;64:496–507. https://doi.org/10.1016/j.addr.2011.11.013 . - DOI - PubMed - PMC
Publication types
LinkOut - more resources
Full Text Sources